Staging Procedures to Diagnose Malignant Pleural Mesothelioma

Status

Terminated

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02648763

Enrollment

Registered

2016-01-07

Start date

2016-01-15

Completion date

2023-04-22

Last updated

2025-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mesothelioma, Solitary Fibrous Tumor of the Pleura

Brief summary

The purpose of this study is to evaluate the accuracy of participants imaging versus staging procedures. The investigators will consent subjects that are scheduled to undergo staging procedures to diagnose malignant pleural mesothelioma (including pleuroscopy, bronchoscopy, endobronchial ultrasound and laparoscopy) as part of their standard of care.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Subject provides informed consent * Subject is \>18 years of age * Subject is deemed competent for making medical decisions * Subject is scheduled to undergo a staging pleuroscopy * Subject is a surgical candidate * A negative pregnancy test is required in women of child-bearing potential, as standard of care.

Exclusion criteria

* Subject is \<18 years old.

Design outcomes

Primary

Measure	Time frame	Description
Accuracy of surgical staging versus imaging procedures based on surgical findings.	2 years	The staging imaging will be compared with the actual surgical staging procedure to evaluate the accuracy of the imaging.

Countries

United States

Outcome results